FORBES REGIONAL HOSPITAL
The Sunshine Act requires manufacturers to report payments to teaching hospitals as institutions, separately from payments to individual physicians. These figures are money reported to the hospital itself — most of it research funding and grants, not compensation to any named doctor.
- Total reported
- $117K
- Transactions
- 55
- Companies
- 17
- Average per transaction
- $2,119
Who reported the payments
| Mallinckrodt Hospital Products Inc. | $19,741 |
| Olympus America Inc. | $14,199 |
| Genentech USA, Inc. | $13,500 |
| Novartis | $11,500 |
| ZOLL Medical Corporation | $10,400 |
| Linvatec Corporation | $8,615 |
| Aesculap Implant Systems, LLC | $8,386 |
| Genentech, Inc. | $7,500 |
| AstraZeneca | $7,000 |
| Zimmer Biomet | $3,225 |
| Stryker | $3,190 |
| Merck | $2,930 |
| Eisai Inc. | $2,000 |
| Vitalant | $1,800 |
| Bio-rad Laboratories, Inc. | $1,230 |
| CSL Behring | $1,169 |
| Institute For Transfusion Medicine | $150 |